{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:31:30Z","timestamp":1790814690558,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T00:00:00Z","timestamp":1699056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T00:00:00Z","timestamp":1699056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U24 CA171524"],"award-info":[{"award-number":["U24 CA171524"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R37CA222793"],"award-info":[{"award-number":["R37CA222793"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA105274"],"award-info":[{"award-number":["R01 CA105274"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01 CA195565"],"award-info":[{"award-number":["U01 CA195565"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R50CA211115"],"award-info":[{"award-number":["R50CA211115"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Geoffrey Beene Cancer Research Center at Memorial Sloan Kettering Cancer Center","award":["Geoffrey Beene Cancer Research Center at Memorial Sloan Kettering Cancer Center"],"award-info":[{"award-number":["Geoffrey Beene Cancer Research Center at Memorial Sloan Kettering Cancer Center"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s10549-023-07126-4","type":"journal-article","created":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T04:44:16Z","timestamp":1699073056000},"page":"565-574","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Assessment of breast cancer chemotherapy dose reduction in an integrated healthcare delivery system"],"prefix":"10.1007","volume":"203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9124-5323","authenticated-orcid":false,"given":"Elizabeth D.","family":"Kantor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelli","family":"O\u2019Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac J.","family":"Ergas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Valice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janise M.","family":"Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Bhimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narre","family":"Heon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer J.","family":"Griggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin JA","family":"Bowles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna R.","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Kolevska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa V","family":"Bandera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence H","family":"Kushi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,4]]},"reference":[{"key":"7126_CR1","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1001\/archinte.165.11.1267","volume":"165","author":"JJ Griggs","year":"2005","unstructured":"Griggs JJ, Sorbero ME, Lyman GH (2005) Undertreatment of obese women receiving breast cancer chemotherapy. Arch Intern Med 165:1267\u20131273","journal-title":"Arch Intern Med"},{"key":"7126_CR2","doi-asserted-by":"publisher","first-page":"4524","DOI":"10.1200\/JCO.2003.05.002","volume":"21","author":"GH Lyman","year":"2003","unstructured":"Lyman GH, Dale DC, Crawford J (2003) Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices. J Clin Oncology: Official J Am Soc Clin Oncol 21:4524\u20134531","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"key":"7126_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1023\/A:1010635328299","volume":"66","author":"Y Madarnas","year":"2001","unstructured":"Madarnas Y, Sawka CA, Franssen E, Bjarnason GA (2001) Are medical oncologists biased in their treatment of the large woman with breast cancer? Breast Cancer Res Treat 66:123\u2013133","journal-title":"Breast Cancer Res Treat"},{"key":"7126_CR4","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s12032-014-0881-z","volume":"31","author":"JP Carroll","year":"2014","unstructured":"Carroll JP, Protani MM, Nguyen L, Cheng ME, Fay M, Saleem M, Pillay PS, Walpole E, Martin JH (2014) Toxicity and tolerability of adjuvant breast cancer chemotherapy in obese women. Med Oncol 31:881","journal-title":"Med Oncol"},{"key":"7126_CR5","first-page":"5655","volume":"33","author":"S Gouerant","year":"2013","unstructured":"Gouerant S, Leheurteur M, Chaker M, Modzelewski R, Rigal O, Veyret C, Lauridant G, Clatot F (2013) A higher body mass index and fat mass are factors predictive of docetaxel dose intensity. Anticancer Res 33:5655\u20135662","journal-title":"Anticancer Res"},{"key":"7126_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1200\/JCO.2006.08.3063","volume":"25","author":"JJ Griggs","year":"2007","unstructured":"Griggs JJ, Culakova E, Sorbero ME, van Ryn M, Poniewierski MS, Wolff DA, Crawford J, Dale DC, Lyman GH (2007) Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy. J Clin Oncology: Official J Am Soc Clin Oncol 25:277\u2013284","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"key":"7126_CR7","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1002\/cncr.23416","volume":"112","author":"CG Greenman","year":"2008","unstructured":"Greenman CG, Jagielski CH, Griggs JJ (2008) Breast cancer adjuvant chemotherapy dosing in obese patients: dissemination of information from clinical trials to clinical practice. Cancer 112:2159\u20132165","journal-title":"Cancer"},{"key":"7126_CR8","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1200\/JCO.2011.39.9436","volume":"30","author":"JJ Griggs","year":"2012","unstructured":"Griggs JJ, Mangu PB, Anderson H, Balaban EP, Dignam JJ, Hryniuk WM, Morrison VA, Pini TM, Runowicz CD, Rosner GL, Shayne M, Sparreboom A et al (2012) Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncology: Official J Am Soc Clin Oncol 30:1553\u20131561","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"key":"7126_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1023\/A:1025481505537","volume":"81","author":"JJ Griggs","year":"2003","unstructured":"Griggs JJ, Sorbero ME, Stark AT, Heininger SE, Dick AW (2003) Racial disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy. Breast Cancer Res Treat 81:21\u201331","journal-title":"Breast Cancer Res Treat"},{"key":"7126_CR10","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1001\/jamaoncol.2015.1796","volume":"1","author":"EV Bandera","year":"2015","unstructured":"Bandera EV, Lee VS, Rodriguez-Rodriguez L, Powell CB, Kushi LH (2015) Impact of Chemotherapy Dosing on Ovarian Cancer Survival according to body Mass Index. JAMA Oncol 1:737\u2013745","journal-title":"JAMA Oncol"},{"key":"7126_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10549-006-9254-4","volume":"100","author":"M Shayne","year":"2006","unstructured":"Shayne M, Crawford J, Dale DC, Culakova E, Lyman GH, Group ANCS (2006) Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy. Breast Cancer Res Treat 100:255\u2013262","journal-title":"Breast Cancer Res Treat"},{"key":"7126_CR12","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s10552-008-9170-5","volume":"19","author":"ML Kwan","year":"2008","unstructured":"Kwan ML, Ambrosone CB, Lee MM, Barlow J, Krathwohl SE, Ergas IJ, Ashley CH, Bittner JR, Darbinian J, Stronach K, Caan BJ, Davis W et al (2008) The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California. Cancer Causes Control 19:1065\u20131076","journal-title":"Cancer Causes Control"},{"key":"7126_CR13","doi-asserted-by":"crossref","unstructured":"Mandelblatt JS, Luta G, Kwan ML, Makgoeng SB, Ergas IJ, Roh JM, Sternfeld B, Adams-Campbell LL, Kushi LH (2011) Associations of physical activity with quality of life and functional ability in breast cancer patients during active adjuvant treatment: the Pathways Study. Breast cancer research and treatment ;129: 521-9","DOI":"10.1007\/s10549-011-1483-5"},{"key":"7126_CR14","doi-asserted-by":"crossref","unstructured":"Ergas IJ, Cespedes Feliciano EM, Bradshaw PT, Roh JM, Kwan ML, Cadenhead J, Santiago-Torres M, Troeschel AN, Laraia B, Madsen K, Kushi LH (2021) Diet quality and breast Cancer recurrence and survival: the Pathways Study. JNCI Cancer Spectr ;5","DOI":"10.1093\/jncics\/pkab019"},{"key":"7126_CR15","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1056\/NEJM198710223171717","volume":"317","author":"RD Mosteller","year":"1987","unstructured":"Mosteller RD (1987) Simplified calculation of body-surface area. N Engl J Med 317:1098","journal-title":"N Engl J Med"},{"key":"7126_CR16","unstructured":"National Comprehensive Cancer Network"},{"key":"7126_CR17","doi-asserted-by":"publisher","first-page":"5909","DOI":"10.1158\/1078-0432.CCR-16-1119","volume":"22","author":"EV Bandera","year":"2016","unstructured":"Bandera EV, Lee VS, Rodriguez-Rodriguez L, Powell CB, Kushi LH (2016) Racial\/Ethnic disparities in Ovarian Cancer Treatment and Survival. Clin Cancer Res 22:5909\u20135914","journal-title":"Clin Cancer Res"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-023-07126-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-023-07126-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-023-07126-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T11:20:19Z","timestamp":1706008819000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-023-07126-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,4]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["7126"],"URL":"https:\/\/doi.org\/10.1007\/s10549-023-07126-4","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,4]]},"assertion":[{"value":"20 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Bandera serves in an Advisory Board for Pfizer Clinical Trial Diversity Initiative. Other authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}